ET-743 (Trabectedin)

trabectedin · PharmaMar

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ET-743 (Trabectedin), covering 2011-04-28 to 2011-04-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer [Phase 2]